Variations in five genes and the severity of age-related macular degeneration: Results from the Muenster aging and retina study

Eye

Volumn 23, Issue 12, 2009, Pages 2238-2244

  Farwick, A ^a   Dasch, B ^a   Weber, B H F ^b   Pauleikhoff, D ^c   Stoll, M ^a   Hense, H W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

Age related macular degeneration; ARMS2; C2; CFB; CFH; HtrA1; Severity

Indexed keywords

AGE RELATED MACULOPATHY SUSCEPTIBILITY; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT FACTOR H; EYE PROTEIN; HTRA SERINE PEPTIDASE 1; PEPTIDASE; UNCLASSIFIED DRUG;

AGED; AGING; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; COMPLEMENT C2; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; FEMALE; FUNDUS OCULI; GENE FREQUENCY; HUMANS; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RETINA; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES; SEVERITY OF ILLNESS INDEX;

EID: 72749123983     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.426     Document Type: Article

References (43)

1. De Jong PT. Age-related macular degeneration. N Engl J Med 2006; 355: 1474-1485.
2. Van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG et al. Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology 2003; 110: 1540-1544.
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age- related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
4. De Jong PT, Bergen AA, Klaver CC, Van Duijn CM, Assink JM. Age-related maculopathy: its genetic basis. Eye 2001; 15: 396-400.
5. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS et al. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 2005; 123: 1570-1574.
6. Scholl HP, Fleckenstein M, Issa PC, Keilhauer C, Holz FG, Weber BH. An update on the genetics of age-related macular degeneration. Mol Vis 2007; 13: 196-205.
7. Edwards AO, Ritter IR, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science 2005; 308: 421-424.
8. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
9. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-421.
10. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
11. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389-407.
12. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger Tet al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227-3236.
13. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78: 852-864.
14. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 2008; 40: 892-896.
15. Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007; 104: 16227-16232.
16. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992.
17. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314: 992-993.
18. Gibbs D, Yang Z, Constantine R, Ma X, Camp NJ, Yang X et al. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res 2008; 48: 685-689.
19. Yoshida T, Dewan A, Zhang H, Sakamoto R, Okamoto H, Minami M et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 2007; 13: 545-548.
20. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS ONE 2008; 3: e2199.
21. Spencer KL, Hauser MA, Olson LM, Olson LM, Schmidt S, Scott WK et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007; 16: 1986-1992. (Pubitemid 47354881)
22. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 1055-1059.
23. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al., AMD Genetics Clinical Study Group. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-462.
24. Despriet DD, Klaver CC,Witteman JC, Witteman JC, Bergen AA, Kardys I et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006; 296: 301-309.
25. Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, Klein ML. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS ONE 2007; 2: e1197.
26. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2005; 3: e5.
27. Shuler Jr RK, Schmidt S, Gallins P, Hauser MA, Scott WK, Caldwell J et al. Phenotype analysis of patients with the risk variant LOC387715 (A69S) in age-related macular degeneration. Am J Ophthalmol 2008; 145: 303-307.
28. Shuler Jr RK, Schmidt S, Gallins P, Hauser MA, Scott WK, Caldwell J et al. Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration. Ophthalmology 2008; 115: 520-524.
29. Tedeschi-Blok N, Buckley J, Varma R, Triche TJ, Hinton DR. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Ophthalmology 2007; 114: 99-103.
30. Dewan A, Bracken MB, Hoh J. Two genetic pathways for age-related macular degeneration. Curr Opin Genet Dev 2007; 17: 228-233.
31. Weger M, Renner W, Steinbrugger I, Kö fer K, Wedrich A, Groselj-Strele A et al. Association of the HTRA1 -625G4A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis 2007; 13: 1274-1279. (Pubitemid 47128954)
32. Dasch B, Fuhs A, Schmidt J, Behrens T, Meister A, Wellmann J et al. Serum levels of macular carotenoids in relation to age-related maculopathy The Muenster Aging and Retina Study (MARS). Graefes Arch Clin Exp Ophthalmol 2005; 243: 1028-1035.
33. Dasch B, Fuhs A, Meister A, Behrens T, Krause K, Pauleikhoff D et al. [Association between classic cardiovascular risk factors and age-related maculopathy (ARM) Results of the baseline examination of the Munster Aging and Retina Study (MARS).]. Ophthalmologe 2005; 102: 1057-1063.
34. Dasch B, Fuhs A, Behrens T, Meister A, Wellmann J, Fobker M et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol 2005; 123: 1501-1506.
35. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
36. Leveziel N, Souied EH, Richard F, Barbu V, Zourdani A, Morineau G et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007; 13: 2153-2159.
37. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
38. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, Van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 2006; 8: 395-400.
39. Lin JM, Tsai YY, Wan L, Lin HJ, Tsai Y, Lee CC et al. Complement factor H variant increases the risk for early age-related macular degeneration. Retina 2008; 28: 1416-1420.
40. Rothman KJ. Epidemiology: An Introduction. Oxford University press: New York, 2002.
41. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006; 51: 137-152. (Pubitemid 43269939)
42. Rodriguez DC, Esparza-Gordillo J, Goicoechea DJ, Lopez- Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004; 41: 355-367.
43. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784-2790. (Pubitemid 44400405)